Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...

The U.S. Food and Drug Administration ... insulin biosimilar products approved in 2021 by the FDA,” the agency stated. The FDA granted approval of Merilog to Sanofi (SNY)-Aventis U.S. Published ...

The drugs are listed in alphabetical order. Aprepitant oral suspension: Merck reported a shortage of Emend, its aprepitant oral suspension. Merck did not provide a reason for the shortage. The ...

Like Novolog, Sanofi-Aventis' drug should be administered five to 10 ... joining two long-acting biosimilar products approved in 2021.

The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three biosimilar insulin products to treat diabetes,” said Peter Stein, M.D., director of the Office of New ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Sanofi stock is surging with a Golden Cross formation and promising Dupixent results. With FDA review and potential approval, investors are excited.

One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...

The last few years have been tough for the insulin market, with recent policies and high-level pressure forcing companies to ...